Scope
This House summary covers selected recommendations from the multisociety guideline on sacroiliac-joint complex pain. It distinguishes pain within the joint from posterior ligament pain, diagnostic injections from prognostic blocks, and symptom improvement from proof of a particular pain generator. Many interventions have low-certainty evidence. The guideline records disagreement over block thresholds, especially before fusion; those uncertainties remain part of this summary.
Written by House with AI assistance · AI-assisted source check 29 October 2026.
This is House’s summary of the cited guidance. The source check is not an independent clinician review. Open the publication for complete recommendations, exceptions, evidence grades and later amendments.
Define the suspected pain source
- Use history and provocation tests to guide investigation, not as a stand-alone diagnosis of sacroiliac pain. Negative tests are more predictive than positive tests (high certainty). Diagnostic intra-articular injection may still be reasonable with strong clinical suspicion after other causes have been evaluated. [1]
- Imaging should help exclude other causes such as radiculopathy, hip disease, inflammatory arthropathy, tumour or infection. Do not rely on imaging alone to diagnose non-inflammatory sacroiliac pain or predict fusion response; MRI and other imaging tests have important diagnostic-evidence limitations. [1]
- Intra-articular local-anaesthetic injections have moderate-certainty diagnostic validity for intra-articular pain, but do not reliably predict steroid-injection response or sacral lateral branch ablation outcomes. Do not treat these different purposes as interchangeable. [1]
- Sacral lateral branch blocks assess posterior structures, including interosseous and dorsal sacroiliac ligaments and the inferior dorsal joint. They do not reliably anaesthetize the whole intra-articular joint; diagnostic validity for posterior pain does not establish equal prognostic accuracy across all ablation pathways. [1]
Begin with individualized non-invasive care
- Physical therapy and structured exercise may provide intermediate-term benefit, and cognitive behavioural therapy may help when psychological conditions coexist. These are low-certainty, largely indirect findings. Sacroiliac belts may benefit some patients; chiropractic effectiveness remains uncertain. [1]
- Indirect low-certainty evidence supports NSAIDs and SNRIs, but not other antidepressants, for sacroiliac complex pain. Acute opioid benefit is uncertain; the guideline finds no long-term opioid benefit and indirect evidence that acetaminophen is ineffective for this condition. [1]
Perform and interpret injections carefully
- Do not perform landmark-only intra-articular sacroiliac injections (high-certainty recommendation). Prefer fluoroscopic guidance with contrast confirmation unless contrast is contraindicated; image guidance is also strongly encouraged when treating suspected extra-articular involvement. [1]
- For intra-articular injection, use a low total volume, with a maximum of 2.5 mL to limit capsular rupture and spread. Consider stopping at a lower volume if resistance develops. The preferred technique uses inferior joint access, image guidance and contrast when not contraindicated. [1]
- Do not routinely add corticosteroid to local anaesthetic for a purely diagnostic intra-articular injection. It adds no clear diagnostic benefit and may increase injectate spread beyond the joint, reducing specificity (low-certainty recommendation against routine use). [1]
- Consider ultrasound when radiation or contrast is contraindicated, recognizing that equivalent intra-articular accuracy to fluoroscopy is unproven and depends on operator experience and patient characteristics. Low-dose CT can be considered for advanced degeneration or failed fluoroscopic access. [1]
- Avoid routine sedation for diagnostic sacroiliac or prognostic lateral branch injections because it can increase false-positive responses. Therapeutic injections also usually need no sedation; selected severe phobia, vasovagal or movement problems may justify it. If needed, use the lowest dose of short-acting medication. [1]
- Corticosteroid injections may provide short-term relief, with slightly stronger low-certainty evidence for periarticular than intra-articular injection for at least one month. Superiority at three months is uncertain; do not promise durable relief from the injection response. [1]
- Evidence for regenerative injections is limited: dextrose prolotherapy at 6 months and platelet-rich plasma at 3 months have only low-certainty support. Evidence is insufficient for other listed orthobiologics, hyaluronic acid, botulinum toxin and cryoablation. [1]
Select and deliver lateral branch ablation
- Sacral lateral branch radiofrequency ablation can improve appropriately selected chronic sacroiliac complex pain for at least 3 months using an outcome threshold of at least 50% pain reduction. Evidence for benefit lasting at least 6 months is stronger when anatomically invalid techniques are excluded. These are group-level results, not a guarantee for an individual. [1]
- Before posterior sacral-network ablation, use fluoroscopically guided multi-site, multi-depth lateral branch blocks targeting S1–S3 (moderate-certainty recommendation). The evidence supports their use for selection, but no single clinical, imaging or injection feature strongly predicts success. [1]
- The working group recommends a 50% pain-relief cutoff for prognostic lateral branch blocks before ablation (moderate certainty). Record that IPSIS, NASS and the NASS Fellowship Consortium dissented, preferring dual blocks with at least 75% relief. This is a genuine difference in selection criteria. [1]
- During lateral branch ablation, target S1–S3 near the lateral foraminal margins. Consider L5 dorsal-ramus treatment for transitional anatomy or upper-joint pain, and S4 when its foramen is at or above the inferior joint margin. Additional targets depend on anatomy, not a universal fixed list. [1]
- Use an anatomically valid ablation strategy, such as the supported cooled-monopolar or bipolar strip-lesion approaches. Techniques creating larger lesions have moderate-certainty support; a procedure labelled radiofrequency ablation is not necessarily anatomically equivalent to those studied. [1]
- Before lateral branch ablation in an anticoagulated patient, review the risk of interruption with the prescriber or anticoagulation specialist. The guideline states anticoagulants can often continue, but this requires an individual decision. Light or occasionally moderate sedation may be used while the patient remains responsive. [1]
- During lateral branch ablation, maintain safe separation from sacral foramina and confirm electrode position in multiple views, avoiding surgical hardware. Motor stimulation with observation and patient feedback can reduce collateral nerve injury; sensory stimulation alone provides limited safety assurance. [1]
Reserve fusion for carefully selected refractory disease
- Consider fusion only after conservative and less-invasive options fail. Selection should include at least 6 months of non-radicular pain below L5, at least 12 weeks of conservative care, at least 3 of 6 positive provocation tests, exclusion of alternative causes and positive low-volume dual intra-articular anaesthetic blocks without steroid. This selection recommendation has low certainty. [1]
- For fusion selection, the group advises a higher pain-relief threshold than 50% together with functional improvement, but found insufficient evidence to agree a specific cutoff or block count. The document nevertheless favours dual low-volume injections; the dissenting societies specifically require two blocks with at least 75% relief. [1]
- Discuss uncertainty before fusion: minimally invasive lateral fusion has conflicting trial results, including a negative sham-controlled trial, with very-low-certainty evidence. Risks include infection, persistent pain, haematoma, nonunion and device-related problems. The posterior approach is only a low-certainty option for refractory intra-articular degeneration with instability. [1]
- Judge a therapeutic procedure by pain relief plus meaningful functional or other objective benefit. The guideline cites at least a 2-point or 30% pain improvement threshold alongside measures such as satisfaction, quality of life or reduced resource use, rather than treating pain change alone as complete success. [1]
Limitations and use
- This is a focused selection of diagnostic, procedural and selection recommendations. It is not a complete injection, anticoagulant, device-management or surgical protocol.
- The guideline’s mechanistic and treatment recommendations mainly concern non-inflammatory sacroiliac complex pain. Inflammatory arthropathy, infection, tumour, neurological disease and hip or lumbar causes require separate evaluation.
- Certainty is low for many injections and surgical interventions. Fusion selection thresholds remain disputed, and imaging abnormalities or a positive block alone do not guarantee a successful procedure.
This summary is selective and does not reproduce every recommendation. Apply the source’s population, setting and eligibility criteria, together with clinical judgement and local policy.
Summary sources
- Consensus practice guidelines on sacroiliac joint complex pain
Selected recommendation material consulted
Publication details
- Issuing organisation
- Multispecialty international working group
- First published
- 29 November 2025
- Resource type
- Consensus practice guideline · House clinical summary
The source check confirms publication details and the linked edition. It does not certify every recommendation or its suitability for an individual patient. Publisher access conditions may apply.